- Home
- PRQR vs LOVE Comparison
PRQR vs LOVE Comparison
Compare PRQR & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | LOVE |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.5M | 193.2M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PRQR | LOVE |
|---|---|---|
| Price | $1.53 | $15.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $7.25 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 710.7K | 161.8K |
| Earning Date | 05-07-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.28 |
| Revenue | N/A | ★ $697,115,000.00 |
| Revenue This Year | N/A | $4.63 |
| Revenue Next Year | $13.92 | $6.40 |
| P/E Ratio | ★ N/A | $54.71 |
| Revenue Growth | N/A | ★ 2.42 |
| 52 Week Low | $1.33 | $10.33 |
| 52 Week High | $3.10 | $21.06 |
Technical Indicators
Market Signals| Indicator | PRQR | LOVE |
|---|---|---|
| Relative Strength Index (RSI) | 42.73 | 49.74 |
| Support Level | $1.51 | $14.04 |
| Resistance Level | $1.58 | $16.25 |
| Average True Range (ATR) | 0.12 | 0.60 |
| MACD | -0.00 | -0.17 |
| Stochastic Oscillator | 31.67 | 49.63 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
About LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.